SCHEMBL7415262

SCHEMBL7415262

COC(=O)C[C@H](Cc1ccc(-c2ccccc2)cc1)NCP(=O)(OC)OC

nearest known ligand 0.52

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MME P08473 7/20 0.42
ACE P12821 4/20 0.42
MMEL1 Q495T6 3/20 0.40
SRR Q9GZT4 1/20 0.40
PSAT1 Q9Y617 1/20 0.40
CPA1 P15085 1/20 0.40
ACE2 Q9BYF1 1/20 0.40
ACP3 P15309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7415376 0.91 MME (0.48) MMEMMEL1
SCHEMBL7411689 0.84 MME (0.57) MMEACEMMEL1
SCHEMBL7318673 0.82 HDAC1 (0.53)
SCHEMBL7348038 0.82 MME (0.51) MMEACESRRPSAT1CPA1
SCHEMBL7322712 0.82 MME (0.51) MMEACESRRPSAT1CPA1
SCHEMBL7415269 0.78 MME (0.44) MMEACEMMEL1SRRPSAT1
SCHEMBL7407200 0.78 MME (0.47) MMEMMEL1
SCHEMBL7415260 0.78 MME (0.44) MMEACEMMEL1SRRPSAT1
SCHEMBL8921950 0.77 MMEL1 (0.48) MMEMMEL1
SCHEMBL15096356 0.74 SIGMAR1 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0660840-B1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES CIBA GEIGY AG (CH) 1997-05-07 EP disclosed
WO-1996026729-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES AS ECE INHIBITORS CIBA-GEIGY AG (CH) 1996-09-06 WO disclosed
US-5550119-A ENDOTHELIN-CONVERTING ENZYM INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-08-27 US disclosed
EP-0660840-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES. CIBA GEIGY AG (CH) 1995-07-05 EP disclosed
WO-1994005677-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES CIBA-GEIGY AG (CH) 1994-03-17 WO disclosed
US-5250522-A Neutral endopeptidase inhibitors; cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1993-10-05 US disclosed